These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26852128)

  • 61. Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal type.
    Zhao T; Li YX; Wang SL; Jin J; Wang WH; Song YW; Liu YP; Liu XF; Fang H; Ren H; Chen B; Qi SN; Liu QF; Lu NN; Yu ZH
    Ann Hematol; 2013 Mar; 92(3):325-32. PubMed ID: 23100164
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell lymphoma.
    Ke QH; Zhou SQ; Du W; Liang G; Lei Y; Luo F
    Blood Cancer J; 2014 Dec; 4(12):e267. PubMed ID: 25501024
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
    Yamaguchi M; Suzuki R; Kim SJ; Ko YH; Oguchi M; Asano N; Miyazaki K; Terui Y; Kubota N; Maeda T; Kobayashi Y; Amaki J; Soejima T; Saito B; Shimoda E; Fukuhara N; Tsukamoto N; Shimada K; Choi I; Utsumi T; Ejima Y; Kim WS; Katayama N
    Cancer Sci; 2018 Jun; 109(6):2056-2062. PubMed ID: 29601137
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
    Wang H; Li P; Wang L; Xia Z; Huang H; Lu Y; Li Z
    Ann Hematol; 2015 Sep; 94(9):1535-44. PubMed ID: 25990795
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract.
    Huang MJ; Jiang Y; Liu WP; Li ZP; Li M; Zhou L; Xu Y; Yu CH; Li Q; Peng F; Liu JY; Luo F; Lu Y
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):166-74. PubMed ID: 17919841
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
    Tse E; Kwong YL
    Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.
    Zang J; Li C; Luo SQ; Wang JH; Xu M; Zhao LN; Li WW; Yang H; Xiao F; Hitchcock YJ; Shi M
    Ann Hematol; 2015 Apr; 94(4):583-91. PubMed ID: 25409913
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of extranodal natural killer/t-cell lymphoma, nasal type.
    Chaudhary RK; Bhatt VR; Vose JM
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):245-52. PubMed ID: 25659751
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Role of radiotherapy in the treatment of NK/T-cell nasal type and primary cerebral lymphomas].
    Boros A; Michot JM; Hoang-Xuan K; Mazeron R
    Cancer Radiother; 2016 Oct; 20(6-7):535-42. PubMed ID: 27614517
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma.
    Jiang M; Zhang H; Jiang Y; Yang Q; Xie L; Liu W; Zhang W; Ji X; Li P; Chen N; Zhao S; Wang F; Zou L
    Cancer; 2012 Jul; 118(13):3294-301. PubMed ID: 22139825
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma.
    Moon JH; Lee BH; Kim JA; Lee YJ; Chae YS; Yhim HY; Kwak JY; Do YR; Park Y; Song MK; Shin HJ; Kim T; Lee JJ; Yang DH
    Leuk Res; 2016 Oct; 49():80-7. PubMed ID: 27608179
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysis.
    Chen Y; Luo L; Zheng X; Fu H; Yang X; Huang W; Chen L; Zheng Z; Zheng J; Yang T; Liu T; Hu J
    Leuk Lymphoma; 2020 Dec; 61(14):3306-3318. PubMed ID: 32820684
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
    Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
    Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.
    Wang L; Wang H; Li PF; Lu Y; Xia ZJ; Huang HQ; Zhang YJ
    Ann Hematol; 2015 Aug; 94(8):1381-8. PubMed ID: 25865943
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
    Yamaguchi M; Takata K; Yoshino T; Ishizuka N; Oguchi M; Kobayashi Y; Isobe Y; Ishizawa K; Kubota N; Itoh K; Usui N; Miyazaki K; Wasada I; Nakamura S; Matsuno Y; Oshimi K; Kinoshita T; Tsukasaki K; Tobinai K
    Cancer Sci; 2014 Nov; 105(11):1435-41. PubMed ID: 25181936
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
    Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
    Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
    Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.
    Chauchet A; Michallet AS; Berger F; Bedgedjian I; Deconinck E; Sebban C; Antal D; Orfeuvre H; Corront B; Petrella T; Hacini M; Bouteloup M; Salles G; Coiffier B
    J Hematol Oncol; 2012 Jun; 5():27. PubMed ID: 22682004
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The promising outcome with simultaneous integrated boost intensity modulated radiotherapy in confined nasal extranodal NK/T-cell lymphoma.
    Song Y; Li J; Wang S; Zhou Z; Qiao X; Zhao X
    Leuk Lymphoma; 2021 Dec; 62(12):2907-2914. PubMed ID: 34261418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.